Bardy Diagnostics, Inc. — Form D/A

Bardy Diagnostics, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2018-06-08. The offering totals $35.4M, of which $35.4M was reported sold. Industry: Other Health Care.

Offering

• Filed: 2018-06-08
• Form: D/A
• Accession: 0001686365-18-000003
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $35.4M
• Amount sold: $35.4M
• Investors: 13
• Date of first sale: 2016-09-28
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-272267

Issuer

• Name: Bardy Diagnostics, Inc.
• CIK: 0001686365
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2013
• Address: 316 OCCIDENTAL AVENUE SOUTH SUITE B310, SEATTLE, WA, 98104
• Phone: 704-900-7430

Officers, directors & promoters (28)

Showing 25 of 28 people.

Other filings by this issuer (5)

More

• CIK 1686365 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search